{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:25:09Z","timestamp":1792110309738,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.ophtha.2004.05.036","type":"journal-article","created":{"date-parts":[[2004,11,12]],"date-time":"2004-11-12T17:23:03Z","timestamp":1100280183000},"page":"2240-2245","source":"Crossref","is-referenced-by-count":120,"title":["A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy"],"prefix":"10.1016","volume":"111","author":[{"given":"David G.","family":"Charteris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. William","family":"Aylward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Groenewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riaz H.Y.","family":"Asaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catey","family":"Bunce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2004.05.036_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00006982-200005000-00005","article-title":"Primary vitrectomy alone for repair of retinal detachments following cataract surgery","volume":"20","author":"Speicher","year":"2000","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2004.05.036_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/BF00292353","article-title":"Preoperative vitreous hemorrhage associated with rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy?","volume":"234","author":"Duquesne","year":"1996","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.036_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0161-6420(92)31983-9","article-title":"Pseudophakic retinal detachments","volume":"99","author":"Greven","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2004.05.036_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00006982-199414050-00005","article-title":"Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery","volume":"14","author":"Girard","year":"1994","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2004.05.036_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bjo.77.4.199","article-title":"Pars plana vitrectomy for the treatment of rhegmatogenous retinal detachment uncomplicated by advanced proliferative vitreoretinopathy","volume":"77","author":"Gartry","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.036_bib6","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/BF00189354","article-title":"Cryopexy in primary rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy?","volume":"234","author":"Bonnet","year":"1996","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.036_bib7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/BF00448800","article-title":"Primary vitrectomy without scleral buckling for rhegmatogenous retinal detachment","volume":"234","author":"Heimann","year":"1996","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.036_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0002-9394(14)76889-8","article-title":"Causes of failure after initial vitreoretinal surgery for severe proliferative vitreoretinopathy","volume":"111","author":"Lewis","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.036_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0002-9394(14)76890-4","article-title":"Causes of failure after repeat vitreoretinal surgery for recurrent proliferative vitreoretinopathy","volume":"111","author":"Lewis","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.036_bib10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1001\/archopht.1992.01080180042027","article-title":"Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial","volume":"110","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.036_bib11","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/archopht.1992.01080180052028","article-title":"Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial","volume":"110","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.036_bib12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.eye.6700194","article-title":"Proliferative vitreoretinopathy\u2014developments in adjunctive treatment and retinal pathology","volume":"16","author":"Charteris","year":"2002","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2004.05.036_bib13","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/bjo.79.10.953","article-title":"Proliferative vitreoretinopathy: pathobiology, surgical management and adjunctive treatment","volume":"79","author":"Charteris","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.036_bib14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0002-9394(98)00115-9","article-title":"Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial","volume":"126","author":"Wiedemann","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.036_bib15","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0161-6420(01)00589-9","article-title":"Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy: results from a randomized double-blind controlled clinical trial","volume":"108","author":"Asaria","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2004.05.036_bib16","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0161-6420(01)00553-X","article-title":"How to predict proliferative vitreoretinopathy\u2014a prospective study","volume":"108","author":"Asaria","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2004.05.036_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0002-9394(14)76695-4","article-title":"An updated classification of retinal detachment with proliferative vitreoretinopathy","volume":"112","author":"Machemer","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.036_bib18","unstructured":"Access 95 [computer program]. Redmond, WA: Microsoft Corp.; 1997."},{"key":"10.1016\/j.ophtha.2004.05.036_bib19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0161-6420(84)34318-4","article-title":"5-fluorouracil: new applications in complicated retinal detachment for an established antimetabolite","volume":"91","author":"Blumenkranz","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2004.05.036_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/BF02169453","article-title":"Evaluation of a single intravitreal injection of 5-fluorouracil in vitrectomy cases","volume":"227","author":"Blankenship","year":"1989","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.036_bib21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archopht.1991.01080030107048","article-title":"Inhibition of intraocular fibrin formation following infusion of low-molecular-weight heparin during vitrectomy","volume":"109","author":"Iverson","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.036_bib22","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1001\/archopht.1987.01060030116039","article-title":"Selection of therapeutic agents for intraocular proliferative disease","volume":"105","author":"Blumenkranz","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.036_bib23","first-page":"481","article-title":"Retinal pigment epithelium wound closure in vitro","volume":"31","author":"Verstraeten","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2004.05.036_bib24","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/archopht.1992.01080200130040","article-title":"Five-minute treatments with fluorouracil, floxuridine and mitomycin have long-term effects on human Tenon's capsule fibroblasts","volume":"110","author":"Khaw","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.036_bib25","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0161-6420(93)31640-4","article-title":"Effects of intraoperative 5-fluorouracil or mitomycin C on glaucoma filtration in the rabbit","volume":"100","author":"Khaw","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2004.05.036_bib26","series-title":"Medical and Surgical Retina, Advances, Controversies and Management","first-page":"172","article-title":"Pharmacologic treatment of proliferative vitreoretinopathy: interrelationship with the coagulation cascade","author":"Blumenkranz","year":"1993"},{"key":"10.1016\/j.ophtha.2004.05.036_bib27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/archopht.1994.01090150137036","article-title":"Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal implant for the sustained release of fluorouracil","volume":"112","author":"Rubsamen","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.036_bib28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00006982-199313030-00011","article-title":"Silicone oil as a delivery vehicle for BCNU in rabbit proliferative vitreoretinopathy","volume":"13","author":"Arroyo","year":"1993","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2004.05.036_bib29","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0161-6420(95)30850-0","article-title":"Inhibition of experimental proliferative vitreoretinopathy by retroviral vector-mediated transfer of suicide gene","volume":"102","author":"Sakamoto","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2004.05.036_bib30","first-page":"2406","article-title":"An in vivo gene therapy approach for experimental proliferative vitreoretinopathy using the truncated platelet-derived growth factor alpha receptor","volume":"43","author":"Ikuno","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642004009777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642004009777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T03:20:59Z","timestamp":1549077659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642004009777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0161642004009777"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2004.05.036","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}